BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 25613576)

  • 1. Personalized therapeutic strategies for patients with retinitis pigmentosa.
    Zheng A; Li Y; Tsang SH
    Expert Opin Biol Ther; 2015 Mar; 15(3):391-402. PubMed ID: 25613576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells.
    Bassuk AG; Zheng A; Li Y; Tsang SH; Mahajan VB
    Sci Rep; 2016 Jan; 6():19969. PubMed ID: 26814166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene and Induced Pluripotent Stem Cell Therapy for Retinal Diseases.
    Maeda A; Mandai M; Takahashi M
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():201-216. PubMed ID: 31018110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Correction Recovers Phagocytosis in Retinal Pigment Epithelium Derived from Retinitis Pigmentosa-Human-Induced Pluripotent Stem Cells.
    Artero-Castro A; Long K; Bassett A; Ávila-Fernandez A; Cortón M; Vidal-Puig A; Jendelova P; Rodriguez-Jimenez FJ; Clemente E; Ayuso C; Erceg S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele-Specific Knockout by CRISPR/Cas to Treat Autosomal Dominant Retinitis Pigmentosa Caused by the G56R Mutation in NR2E3.
    Diakatou M; Dubois G; Erkilic N; Sanjurjo-Soriano C; Meunier I; Kalatzis V
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of CRISPR/Cas9 technologies combined with iPSCs in the study and treatment of retinal degenerative diseases.
    Cai B; Sun S; Li Z; Zhang X; Ke Y; Yang J; Li X
    Hum Genet; 2018 Sep; 137(9):679-688. PubMed ID: 30203114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene editing prospects for treating inherited retinal diseases.
    Benati D; Patrizi C; Recchia A
    J Med Genet; 2020 Jul; 57(7):437-444. PubMed ID: 31857428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized Medicine: Cell and Gene Therapy Based on Patient-Specific iPSC-Derived Retinal Pigment Epithelium Cells.
    Li Y; Chan L; Nguyen HV; Tsang SH
    Adv Exp Med Biol; 2016; 854():549-55. PubMed ID: 26427458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo CRISPR/Cas9-Mediated Genome Editing Mitigates Photoreceptor Degeneration in a Mouse Model of X-Linked Retinitis Pigmentosa.
    Hu S; Du J; Chen N; Jia R; Zhang J; Liu X; Yang L
    Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):31. PubMed ID: 32330228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical Strategies.
    Liu W; Liu S; Li P; Yao K
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cells for investigation and treatment of inherited retinal disease.
    Tucker BA; Mullins RF; Stone EM
    Hum Mol Genet; 2014 Sep; 23(R1):R9-R16. PubMed ID: 24647603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome Surgery and Gene Therapy in Retinal Disorders.
    Chan L; Mahajan VB; Tsang SH
    Yale J Biol Med; 2017 Dec; 90(4):523-532. PubMed ID: 29259518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications.
    Chang CY; Ting HC; Su HL; Jeng JR
    Cell Transplant; 2018 Mar; 27(3):379-392. PubMed ID: 29806481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa.
    Tsai YT; Wu WH; Lee TT; Wu WP; Xu CL; Park KS; Cui X; Justus S; Lin CS; Jauregui R; Su PY; Tsang SH
    Ophthalmology; 2018 Sep; 125(9):1421-1430. PubMed ID: 29759820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
    Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
    Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoreceptor cell replacement in macular degeneration and retinitis pigmentosa: A pluripotent stem cell-based approach.
    Gagliardi G; Ben M'Barek K; Goureau O
    Prog Retin Eye Res; 2019 Jul; 71():1-25. PubMed ID: 30885665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome Editing and Its Applications in Model Organisms.
    Ma D; Liu F
    Genomics Proteomics Bioinformatics; 2015 Dec; 13(6):336-44. PubMed ID: 26762955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concise Review: Human Induced Pluripotent Stem Cell Models of Retinitis Pigmentosa.
    Artero Castro A; Lukovic D; Jendelova P; Erceg S
    Stem Cells; 2018 Apr; 36(4):474-481. PubMed ID: 29345014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.